Stocks and Investing Stocks and Investing
Tue, September 17, 2024

Mitchell Kapoor Reiterated (SMMT) at Strong Buy and Held Target at $45 on, Sep 17th, 2024


Published on 2024-10-28 14:17:57 - WOPRAI, Mitchell Kapoor
  Print publication without navigation


Mitchell Kapoor of HC Wainwright & Co., Reiterated "Summit Therapeutics Inc." (SMMT) at Strong Buy and Held Target at $45 on, Sep 17th, 2024.

Mitchell has made no other calls on SMMT in the last 4 months.



There are 2 other peers that have a rating on SMMT. Out of the 2 peers that are also analyzing SMMT, 0 agree with Mitchell's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Mitchell


  • Bradley Canino of "Stifel" Maintained at Strong Buy with Increased Target to $25 on, Monday, September 9th, 2024
  • Yigal Nochomovitz of "Citigroup" Maintained at Strong Buy with Increased Target to $19 on, Monday, September 9th, 2024

Contributing Sources